Diebold Nixdorf (NYSE:DBD – Get Free Report) issued its earnings results on Thursday. The technology company reported $0.60 EPS for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.01), Zacks reports. The company had revenue of $888.20 million during the quarter, compared to the consensus estimate of $846.23 million. Diebold Nixdorf had a return on equity of 18.82% and a net margin of 2.80%. Diebold Nixdorf updated its FY 2026 guidance to 5.250-5.75 EPS.
Here are the key takeaways from Diebold Nixdorf’s conference call:
- Company reported a strong Q1 with $888M revenue (+6% YoY), adjusted EBITDA of $99M (+14% YoY), non-GAAP EPS $0.67 (+81% YoY), and guidance for 2026 revenue of $3.86B–$3.94B and adjusted EBITDA of $510M–$535M.
- Banking momentum — ATMs and branch automation are expanding (large DN Series recycler rollout to a >1M‑member credit union, a 100% teller cash recycler displacement at a major U.S. bank, FOREX ATM outsourcing), supporting higher product margins and pipeline growth.
- Retail acceleration — revenue up ~26% YoY driven by Europe and a ~70% increase in North America off a small base, with major wins for POS and initial self‑checkout deployments and growing Smart Vision AI adoption.
- Services margin was modestly down as management is investing in field technicians and software to improve SLAs and efficiency; these investments compressed near‑term margins but are expected to drive sequential margin expansion and higher service density over time.
- Strong cash generation and balance sheet — Q1 free cash flow tripled to ~$21M, net leverage 1.2x, ~$680M liquidity, Fitch BB‑ rating initiated, $55M repurchased in Q1 (>$117M remaining), and a target of 50%+ FCF conversion and $800M cumulative FCF (2025–2027).
Diebold Nixdorf Stock Up 1.1%
Shares of DBD traded up $0.86 during mid-day trading on Friday, hitting $77.67. The company’s stock had a trading volume of 460,214 shares, compared to its average volume of 750,580. The company’s 50-day moving average is $79.34 and its 200-day moving average is $70.80. Diebold Nixdorf has a 52-week low of $43.61 and a 52-week high of $89.05. The firm has a market capitalization of $2.70 billion, a price-to-earnings ratio of 29.99 and a beta of 1.16. The company has a current ratio of 1.28, a quick ratio of 0.92 and a debt-to-equity ratio of 0.92.
Trending Headlines about Diebold Nixdorf
- Positive Sentiment: Q1 financial beat — Revenue grew ~6% year‑over‑year and results topped estimates; the company reported strong adjusted EBITDA and EPS ahead of expectations, supporting upside to near‑term earnings momentum. Diebold Nixdorf Reports First Quarter Financial Results
- Positive Sentiment: Cash flow and margins improved — Q1 free cash flow more than tripled year‑over‑year and adjusted EBITDA margin expanded, giving the company more flexibility for reinvestment or debt reduction. Diebold Nixdorf Reports First Quarter Financial Results
- Positive Sentiment: Operational momentum — Sales and order backlog improved sequentially; quarterly revenue and EPS beats (revenue ~$888.2M; EPS $0.67 vs. consensus ~$0.61) were highlighted in market coverage and investor materials. Diebold Nixdorf’s (NYSE:DBD) Q1 CY2026 Sales Top Estimates
- Neutral Sentiment: Guidance largely reaffirmed — Management reiterated FY‑2026 guidance with EPS of $5.25–$5.75 and revenue near $3.9B (range centered close to consensus), which reduces forecast uncertainty but leaves limited surprise potential. Diebold Nixdorf Reports First Quarter Financial Results
- Neutral Sentiment: Earnings call & materials available — Management’s comments in the call and slide deck will be key to assessing sustainability of margin and cash‑flow improvements; transcript and presentation provide detail for analysts. DBD Q1 2026 Earnings Call Transcript Q1 Results – Earnings Call Presentation
- Negative Sentiment: Valuation and margin context — the stock trades at a relatively elevated P/E (~30) versus some peers; investors may expect continued execution to justify the premium and could be sensitive to any slowdown in margin expansion. DBD Stock Profile
Analysts Set New Price Targets
Several brokerages have recently weighed in on DBD. Wedbush set a $100.00 price target on shares of Diebold Nixdorf in a research report on Friday, February 13th. Weiss Ratings raised shares of Diebold Nixdorf from a “hold (c+)” rating to a “buy (b)” rating in a research report on Tuesday, February 17th. Finally, DA Davidson reaffirmed a “buy” rating and issued a $100.00 price target on shares of Diebold Nixdorf in a research report on Tuesday, April 21st. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $100.00.
View Our Latest Stock Analysis on DBD
Insider Buying and Selling
In related news, major shareholder Millstreet Capital Management sold 60,833 shares of the stock in a transaction that occurred on Thursday, April 16th. The shares were sold at an average price of $84.77, for a total transaction of $5,156,813.41. Following the completion of the sale, the insider owned 4,704,438 shares of the company’s stock, valued at $398,795,209.26. This represents a 1.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders have sold a total of 512,234 shares of company stock worth $42,516,215 over the last three months. Corporate insiders own 1.10% of the company’s stock.
Institutional Investors Weigh In On Diebold Nixdorf
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Arrowstreet Capital Limited Partnership raised its holdings in shares of Diebold Nixdorf by 458.6% in the third quarter. Arrowstreet Capital Limited Partnership now owns 402,603 shares of the technology company’s stock worth $22,960,000 after buying an additional 330,526 shares during the last quarter. Two Sigma Investments LP raised its holdings in shares of Diebold Nixdorf by 249.0% in the third quarter. Two Sigma Investments LP now owns 119,443 shares of the technology company’s stock worth $6,812,000 after buying an additional 85,223 shares during the last quarter. Qube Research & Technologies Ltd raised its holdings in shares of Diebold Nixdorf by 497.2% in the third quarter. Qube Research & Technologies Ltd now owns 91,997 shares of the technology company’s stock worth $5,247,000 after buying an additional 76,593 shares during the last quarter. First Trust Advisors LP raised its holdings in shares of Diebold Nixdorf by 771.8% in the fourth quarter. First Trust Advisors LP now owns 82,445 shares of the technology company’s stock worth $5,597,000 after buying an additional 72,988 shares during the last quarter. Finally, Marshall Wace LLP raised its holdings in shares of Diebold Nixdorf by 75.2% in the second quarter. Marshall Wace LLP now owns 159,632 shares of the technology company’s stock worth $8,844,000 after buying an additional 68,503 shares during the last quarter. Hedge funds and other institutional investors own 97.04% of the company’s stock.
Diebold Nixdorf Company Profile
Diebold Nixdorf, Inc (NYSE: DBD) is a leading global provider of connected commerce solutions, specializing in automated teller machines (ATMs), point-of-sale (POS) systems and related software and services for the banking and retail industries. The company’s core offerings include hardware platforms, software applications for transaction management and advanced analytics tools that enable financial institutions and retailers to enhance customer engagement, streamline operations and improve security at the point of transaction.
See Also
Receive News & Ratings for Diebold Nixdorf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diebold Nixdorf and related companies with MarketBeat.com's FREE daily email newsletter.
